PTX-3, yet poorly understood, seems to be a pioneer in regulating cancer in both ways: it could settle an initial proper immune and inflammatory response and subsequently inhibit tumor progression, or it could increase metastatic risk. This evidence concerns the gene PTX3 and neoplasm.